• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎球菌疫苗接种可减少动脉粥样硬化病变形成:肺炎链球菌与氧化型低密度脂蛋白之间的分子模拟。

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

作者信息

Binder Christoph J, Hörkkö Sohvi, Dewan Asheesh, Chang Mi-Kyung, Kieu Emily P, Goodyear Carl S, Shaw Peter X, Palinski Wulf, Witztum Joseph L, Silverman Gregg J

机构信息

Divisions of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0682 USA.

出版信息

Nat Med. 2003 Jun;9(6):736-43. doi: 10.1038/nm876. Epub 2003 May 12.

DOI:10.1038/nm876
PMID:12740573
Abstract

During the progression of atherosclerosis, autoantibodies are induced to epitopes of oxidized low-density lipoprotein (oxLDL) and active immunization of hypercholesterolemic mice with oxLDL ameliorates atherogenesis. We unexpectedly found that many autoantibodies to oxLDL derived from 'naive' atherosclerotic mice share complete genetic and structural identity with antibodies from the classic anti-phosphorylcholine B-cell clone, T15, which protect against common infectious pathogens, including pneumococci. To investigate whether in vivo exposure to pneumococci can affect atherogenesis, we immunized Ldlr(-/-) mice with Streptococcus pneumoniae. This induced high circulating levels of oxLDL-specific IgM and a persistent expansion of oxLDL-specific T15 IgM-secreting B cells primarily in the spleen, which were cross-reactive with pneumococcal determinants. Pneumococcal immunization decreased the extent of atherosclerosis, and plasma from these mice had an enhanced capacity to block the binding of oxLDL to macrophages. These studies show molecular mimicry between epitopes of oxLDL and S. pneumoniae and indicate that these immune responses can have beneficial effects.

摘要

在动脉粥样硬化进展过程中,会诱导产生针对氧化型低密度脂蛋白(oxLDL)表位的自身抗体,用oxLDL对高胆固醇血症小鼠进行主动免疫可改善动脉粥样硬化的发生。我们意外地发现,许多源自“未接触过抗原的”动脉粥样硬化小鼠的抗oxLDL自身抗体与经典抗磷酸胆碱B细胞克隆T15产生的抗体具有完全相同的基因和结构,T15抗体可抵御包括肺炎球菌在内的常见感染性病原体。为了研究体内接触肺炎球菌是否会影响动脉粥样硬化的发生,我们用肺炎链球菌免疫Ldlr(-/-)小鼠。这诱导了循环中高水平的oxLDL特异性IgM以及主要在脾脏中持续扩增的分泌oxLDL特异性T15 IgM的B细胞,这些B细胞与肺炎球菌决定簇具有交叉反应性。肺炎球菌免疫降低了动脉粥样硬化的程度,并且这些小鼠的血浆阻断oxLDL与巨噬细胞结合的能力增强。这些研究表明oxLDL和肺炎链球菌的表位之间存在分子模拟,并表明这些免疫反应可能具有有益作用。

相似文献

1
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.肺炎球菌疫苗接种可减少动脉粥样硬化病变形成:肺炎链球菌与氧化型低密度脂蛋白之间的分子模拟。
Nat Med. 2003 Jun;9(6):736-43. doi: 10.1038/nm876. Epub 2003 May 12.
2
Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.肺炎球菌疫苗接种后对氧化型低密度脂蛋白及相关细菌抗原的体液免疫反应。
Transl Res. 2007 Sep;150(3):172-9. doi: 10.1016/j.trsl.2007.04.001. Epub 2007 May 25.
3
Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.氧化型低密度脂蛋白抗体:心血管疾病的流行病学研究及潜在临床应用
Minerva Cardioangiol. 2007 Dec;55(6):821-37.
4
Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.重新审视氧化型低密度脂蛋白,其在动脉粥样硬化发生中的作用以及与之相关的免疫反应。
Arch Immunol Ther Exp (Warsz). 2004 Jul-Aug;52(4):225-39.
5
Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.动脉粥样硬化发展过程中氧化型低密度脂蛋白抗体——临床与动物研究
Clin Chim Acta. 2004 Oct;348(1-2):1-8. doi: 10.1016/j.cccn.2004.05.021.
6
Phosphorylcholine-targeting immunization reduces atherosclerosis.靶向磷酸胆碱的免疫疗法可减轻动脉粥样硬化。
J Am Coll Cardiol. 2007 Aug 7;50(6):540-6. doi: 10.1016/j.jacc.2006.11.054. Epub 2007 Jul 23.
7
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.病变发展及对免疫的反应揭示了CD4在动脉粥样硬化中具有复杂作用。
Circ Res. 2005 Mar 4;96(4):427-34. doi: 10.1161/01.RES.0000156889.22364.f1. Epub 2005 Jan 20.
8
Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.诱导对氧化型低密度脂蛋白的口服耐受可改善动脉粥样硬化。
Circulation. 2006 Oct 31;114(18):1968-76. doi: 10.1161/CIRCULATIONAHA.106.615609. Epub 2006 Oct 23.
9
Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.母体免疫程序可引发产后免疫反应并减轻后代的动脉粥样硬化。
Circ Res. 2006 Sep 29;99(7):e51-64. doi: 10.1161/01.RES.0000244003.08127.cc. Epub 2006 Aug 31.
10
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.用氧化型低密度脂蛋白脉冲树突状细胞进行免疫接种可减少 LDL 受体缺陷型小鼠的动脉粥样硬化。
Cardiovasc Res. 2010 Feb 1;85(3):622-30. doi: 10.1093/cvr/cvp338. Epub 2009 Oct 9.

引用本文的文献

1
Oral microbiome diversity associates with carotid intima media thickness in middle-aged male subjects.中年男性受试者的口腔微生物群多样性与颈动脉内膜中层厚度相关。
Commun Med (Lond). 2025 Mar 6;5(1):66. doi: 10.1038/s43856-025-00773-2.
2
Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.靶向肠道微生物群以调节动脉粥样硬化中的适应性免疫反应。
Front Cardiovasc Med. 2025 Jan 31;12:1502124. doi: 10.3389/fcvm.2025.1502124. eCollection 2025.
3
A bibliometric analysis of vaccination against atherosclerosis.
一项关于抗动脉粥样硬化疫苗接种的文献计量分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2365500. doi: 10.1080/21645515.2024.2365500. Epub 2024 Jun 19.
4
A correspondence on bibliometric analysis of vaccination against atherosclerosis.关于动脉粥样硬化疫苗接种的文献计量分析通信
Hum Vaccin Immunother. 2024 Dec 31;20(1):2400753. doi: 10.1080/21645515.2024.2400753. Epub 2024 Oct 7.
5
Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.丙二醛特异性天然免疫球蛋白M抑制心肌梗死患者罪犯部位来源的细胞外囊泡触发的中性粒细胞胞外陷阱形成。
Eur Heart J. 2025 Mar 7;46(10):926-939. doi: 10.1093/eurheartj/ehae584.
6
Mini-Review: Immunogenic epitopes in apolipoprotein B-100 for atheroprotective immunization.综述:载脂蛋白B-100中用于动脉粥样硬化保护性免疫的免疫原性表位
Front Cardiovasc Med. 2024 Aug 15;11:1448664. doi: 10.3389/fcvm.2024.1448664. eCollection 2024.
7
Atherosclerosis antigens as targets for immunotherapy.动脉粥样硬化抗原作为免疫治疗的靶点。
Nat Cardiovasc Res. 2023 Dec;2(12):1129-1147. doi: 10.1038/s44161-023-00376-x. Epub 2023 Dec 11.
8
Human circulating CD24 marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease.人外周血循环 CD24 边缘区 B 细胞产生靶向动脉粥样硬化抗原的 IgM,从而提供对血管疾病的保护。
Nat Cardiovasc Res. 2023 Nov;2(11):1003-1014. doi: 10.1038/s44161-023-00356-1. Epub 2023 Oct 30.
9
The immunology of B-1 cells: from development to aging.B-1细胞的免疫学:从发育到衰老
Immun Ageing. 2024 Aug 2;21(1):54. doi: 10.1186/s12979-024-00455-y.
10
Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.颠覆传统:动脉粥样硬化中的抗动脉粥样硬化 IgM 产生 B 细胞。
Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):1906-1915. doi: 10.1161/ATVBAHA.124.319847. Epub 2024 Jul 18.